Failure of combination therapy with acitretin and cyclosporin A in 3 patients with erythrodermic psoriasis.
Kuijpers
A L
AL
van Dooren-Greebe
J V
JV
van de Kerkhof
P C
PC
D017255:Acitretin / Q000008:administration & dosage / Q000627:therapeutic use*; D000368:Aged; D000369:Aged, 80 and over; D002117:Calcitriol / Q000031:analogs & derivatives / Q000627:therapeutic use; D016572:Cyclosporine / Q000008:administration & dosage / Q000627:therapeutic use*; D003873:Dermatitis, Exfoliative / Q000188:drug therapy*; D003879:Dermatologic Agents / Q000627:therapeutic use; D004338:Drug Combinations; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D007641:Keratolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D011379:Prognosis; D011565:Psoriasis / Q000188:drug therapy*
D003879:Dermatologic Agents; D004338:Drug Combinations; D007166:Immunosuppressive Agents; D007641:Keratolytic Agents; C055085:calcipotriene; D016572:Cyclosporine; D002117:Calcitriol; D017255:Acitretin; D008727:Methotrexate